MFDS approves ‘Invossa K Inj,’ Korea’s first gene therapy

The Ministry of Food and Drug Safety(MFDS) announced approval of ‘Invossa K Inj,’ a gene therapy for the treatment of osteoarthritis in the knee, on the 12^th of July.

Gene therapy is a pharmaceutical product is that is a dielectric substance or has cells whose dielectric substance is transformed or introduced into. Kolon Life Science’s ‘Invossa K Inj’ has allogeneic human cartilage cells engin...